Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.67)
# 1,952
Out of 5,116 analysts
305
Total ratings
58.74%
Success rate
-0.94%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.75 | +45.45% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $4.55 | +31.87% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $477.13 | -10.93% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.22 | +30.15% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $47.54 | +40.93% | 3 | Sep 23, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $210 → $222 | $224.65 | -1.18% | 9 | Aug 28, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $134.38 | +7.16% | 15 | Aug 6, 2025 | |
| OMDA Omada Health | Initiates: Overweight | $25 | $15.95 | +56.74% | 1 | Jul 1, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $34.31 | +16.58% | 4 | Jun 11, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $200.60 | +4.69% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $227.64 | -12.14% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $2.63 | +90.11% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $64.21 | +77.54% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $33.58 | +69.74% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $64.94 | +24.73% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $43.69 | -19.89% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.91 | +20.72% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $86.12 | +114.82% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $232.49 | -28.17% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $137.43 | -69.44% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $175.94 | -9.63% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $79.61 | +57.02% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $352.13 | -79.47% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $176.88 | +10.24% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $331.83 | +47.06% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $164.84 | +79.57% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $253.89 | +44.94% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $258.83 | +98.20% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $276.51 | -0.55% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $40.51 | +117.23% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $54.93 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $73.46 | +151.84% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $222.87 | -4.43% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $174.01 | -66.67% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $276.84 | -57.74% | 15 | Jun 16, 2020 |
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.75
Upside: +45.45%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $4.55
Upside: +31.87%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $477.13
Upside: -10.93%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.22
Upside: +30.15%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $47.54
Upside: +40.93%
Veeva Systems
Aug 28, 2025
Maintains: Underweight
Price Target: $210 → $222
Current: $224.65
Upside: -1.18%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $134.38
Upside: +7.16%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $15.95
Upside: +56.74%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $34.31
Upside: +16.58%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $200.60
Upside: +4.69%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $227.64
Upside: -12.14%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $2.63
Upside: +90.11%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $64.21
Upside: +77.54%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $33.58
Upside: +69.74%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $64.94
Upside: +24.73%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $43.69
Upside: -19.89%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.91
Upside: +20.72%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $86.12
Upside: +114.82%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $232.49
Upside: -28.17%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $137.43
Upside: -69.44%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $175.94
Upside: -9.63%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $79.61
Upside: +57.02%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $352.13
Upside: -79.47%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $176.88
Upside: +10.24%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $331.83
Upside: +47.06%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $164.84
Upside: +79.57%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $253.89
Upside: +44.94%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $258.83
Upside: +98.20%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $276.51
Upside: -0.55%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $40.51
Upside: +117.23%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $54.93
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $73.46
Upside: +151.84%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $222.87
Upside: -4.43%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $174.01
Upside: -66.67%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $276.84
Upside: -57.74%